Simultaneous Liver Transplantation and Sleeve Gastrectomy: Prohibitive Combination or a Necessity?

被引：0
作者：
Eviatar Nesher
Eytan Mor
Amir Shlomai
Michal Naftaly-Cohen
Renana Yemini
Alexander Yussim
Marius Brown
Andrei Keidar
机构：
[1] Rabin Medical Center,The Department of Transplantation
[2] Rabin Medical Center,The Liver Institute
[3] Rabin Medical Center,Department of Medicine D
[4] Rabin Medical Center,Department of General Surgery
[5] Beilinson Hospital,The Department of Surgery
来源：
Obesity Surgery | 2017年 / 27卷
关键词：
Liver transplantation; Sleeve gastrectomy; Non-alcoholic steatohepatitis; Liver cirrhosis; Bariatric surgery;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Previously, many morbidly obese (MO) patients were denied liver transplantation (LT) because of the higher operative risk. However, nowadays, 5 and 10 years graft survival is the rule, and patients whose lives can be prolonged with LT are dying of obesity-related comorbidities. Recent experience suggests that weight reduction in MO liver transplant recipients would improve their long-term survival. The bariatric surgery before LT is contraindicated for patients with decompensated cirrhosis, while post-transplant intervention is associated with increased technical difficulty. We present our experience with three patients who underwent simultaneous liver transplantation and sleeve gastrectomy. After a median 13 months follow-up, all patients are alive, having normal allograft function and significant weight loss. Combined liver transplantation with simultaneous sleeve gastrectomy appears technically feasible and relatively safe in selected patients.
引用
收藏
页码：1387 / 1390
页数：3
相关论文
共 27 条
  • [1] Charlton MR(2011)Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States Gastroenterology 141 1249-1253
  • [2] Burns JM(2007)Morbid obesity with one or more other serious comorbidities should be a contraindication for liver transplantation Liver Transpl 13 1627-1629
  • [3] Pedersen RA(2008)Bariatric surgery in liver transplant patients: weighing the evidence Obes Surg 18 1515-1516
  • [4] Thuluvath PJ(2015)Bariatric surgery and liver transplantation: a systematic review a new frontier for bariatric surgery Obes Surg 25 134-142
  • [5] Mandell MS(2012)Recurrence of non-alcoholic steatohepatitis and cryptogenic cirrhosis following orthotopic liver transplantation in the context of the metabolic syndrome Clin Transpl 26 E505-E512
  • [6] Zimmerman M(1999)Increased early morbidity and mortality with acceptable long-term function in severely obese patients undergoing liver transplantation Clin Transpl 13 126-130
  • [7] Campsen J(2011)Increased perioperative mortality following bariatric surgery among patients with cirrhosis Clin Gastroenterol Hepatol 9 897-901
  • [8] Lazzati A(2008)Pharmacokinetics of mycophenolic acid, tacrolimus and sirolimus after gastric bypass surgery in end-stage renal disease and transplant patients: a pilot study Clin Transpl 22 281-291
  • [9] Iannelli A(2013)Combined liver transplantation and gastric sleeve resection for patients with medically complicated obesity and end­stage liver disease Am J Transplant 13 363-368
  • [10] Schneck AS(2016)Combined liver transplantation and sleeve gastrectomy for end-stage liver disease in a bariatric patient: First European case-report Int J Surg Case Rep 28 38-41
123